Novel approach to the formulation of an Epstein-Barr virus antigen-based nasopharyngeal carcinoma vaccine - Wikidata - wikimedia - TriplyDB

Novel approach to the formulation of an Epstein-Barr virus antigen-based nasopharyngeal carcinoma vaccine

Novel approach to the formulation of an Epstein-Barr virus antigen-based nasopharyngeal carcinoma vaccine

http://www.wikidata.org/entity/Q28749468

about

sameAs

Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinoma Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma.The Epstein-Barr Virus Lytic Protein BZLF1 as a Candidate Target Antigen for Vaccine Development.Pre-emptive and therapeutic adoptive immunotherapy for nasopharyngeal carcinoma: Phenotype and effector function of T cells impact on clinical response.Epstein-Barr virus: novel patented therapeutics.Basic consideration of research strategies for head and neck cancer.Construction of a recombinant-BCG containing the LMP2A and BZLF1 genes and its significance in the Epstein-Barr virus positive gastric carcinoma.Human MHC Class I-restricted high avidity CD4+ T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo.

P2860

Q26823898-2C23237D-8A02-4C98-BB9A-2C526BFA874B Q27016002-3E229445-6E73-437E-9CE8-466051D2AD48 Q34242449-99C6F291-7045-4563-866B-E79178DF5A7E Q35815850-DDF01791-13F8-47A5-9434-211FA2C88DB4 Q37705026-C94A00CC-8102-4FDC-BCEA-B2F540334F7D Q37729167-AEB7FDE0-B360-4E75-9D7B-0EE3228E897D Q38051156-2232558E-2269-4F9A-AE9B-85C3EC89C16F Q42226962-23B8EE28-87A4-4543-999F-B8E365082C44 Q43238571-F42A67C2-7F00-47E9-8D18-A03AFB789682

P2860

Novel approach to the formulation of an Epstein-Barr virus antigen-based nasopharyngeal carcinoma vaccine

http://www.wikidata.org/entity/Q28749468

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Novel approach to the formulat ...... sopharyngeal carcinoma vaccine

@ast

Novel approach to the formulat ...... sopharyngeal carcinoma vaccine

@en

Novel approach to the formulat ...... sopharyngeal carcinoma vaccine

@nl

type

label

Novel approach to the formulat ...... sopharyngeal carcinoma vaccine

@ast

Novel approach to the formulat ...... sopharyngeal carcinoma vaccine

@en

Novel approach to the formulat ...... sopharyngeal carcinoma vaccine

@nl

prefLabel

Novel approach to the formulat ...... sopharyngeal carcinoma vaccine

@ast

Novel approach to the formulat ...... sopharyngeal carcinoma vaccine

@en

Novel approach to the formulat ...... sopharyngeal carcinoma vaccine

@nl

P1433

Q28749468-35A0CA9F-95BB-4360-8790-D5E6D152C8BD

P1476

Q28749468-D136C618-30DF-4A50-B6F7-B668D73BC903

P2093

Q28749468-12CBC950-0109-4E37-8DDC-D889950D60D1

Q28749468-36A4D05B-208B-4371-B997-0C933F12E9A4

Q28749468-3C0C03EB-B35C-4B0B-900C-1588C9FC7D40

Q28749468-3F40F9FB-AE2A-4A97-B7E7-5E41CFE681B2

Q28749468-8E6E7EFE-FE44-4E38-A6A1-97BFF26FD8B8

Q28749468-A984596C-F169-43D9-A1CD-12EC53C54D03

Q28749468-D0B96220-F569-48B3-81EF-A8335A854263

Q28749468-DB1C7592-B94D-42BC-B276-EC02245D829F

Q28749468-E35D174B-431F-4E02-B3A3-1E7E4F32AEE7

P2860

Q28749468-02BB4A28-0628-43D4-A601-C18FC5C7A8C2

Q28749468-044A22E4-1685-426E-B950-D5216D9469CC

Q28749468-10CD7803-FC6D-4701-A313-DCD7D65A85B3

Q28749468-157D14F8-9796-41EB-9D9F-28A75C3CFB01

Q28749468-1912970E-DC21-4168-ADE7-5FE79678B75A

Q28749468-1ADF1847-4684-467D-A778-E6B4FA687C81

Q28749468-1C69E53C-2756-4619-A2A7-1E8DF70B45FB

Q28749468-23BE6E4D-407C-4D3B-B52D-7C059EC66073

Q28749468-23F121E3-3BC4-4145-9835-ED77126177C6

Q28749468-36D27D91-1336-480C-824C-DEF945E37FE3

P304

Q28749468-78F22574-3361-4C78-9318-04056ABFBBB3

P31

Q28749468-A1AB2772-B31C-4662-9F2D-FE82A228B061

P356

Q28749468-AE571964-29FD-40BC-8574-39CC82FED72C

P407

Q28749468-DA703B7B-0434-49A8-85C3-45A6A5B7A6FC

P433

Q28749468-521233CB-B492-4A93-8AEE-96E902896DCF

P478

Q28749468-87989DF7-E1FA-425A-8DBA-09AA85942A1A

P577

Q28749468-A5DA5014-D0BE-48F9-8B84-F704FC24FE0C

P5875

Q28749468-3B71F7AB-A18C-48BC-B0EE-3A0187C2914C

P698

Q28749468-22E338F6-69E6-4634-AE97-2E1D85DE6CD6

P921

Q28749468-A4D6273D-28DC-465B-ADCE-CDE6563D989C

P932

Q28749468-47317660-65D5-4373-9D48-A2587427B3BD

P356

P1433

Journal of Virology

P1476

Novel approach to the formulat ...... sopharyngeal carcinoma vaccine

@en

P2093

David F Hall

http://www.w3.org/2001/XMLSchema#string

Denis J Moss

http://www.w3.org/2001/XMLSchema#string

Lea Heslop

http://www.w3.org/2001/XMLSchema#string

Leanne E Morrison

http://www.w3.org/2001/XMLSchema#string

Monika Corban

http://www.w3.org/2001/XMLSchema#string

Pauline Crooks

http://www.w3.org/2001/XMLSchema#string

Scott A Thomson

http://www.w3.org/2001/XMLSchema#string

Viviana P Lutzky

http://www.w3.org/2001/XMLSchema#string

William B Coman

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of pluripotent protective immunity following immunisation with a chimeric vaccine against human cytomegalovirus

Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma

A geometric and algebraic view of MHC-peptide complexes and their binding properties

New allele frequency database: http://www.allelefrequencies.net

HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.

The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease.

Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma.

Hodgkin disease: prognostic factors and treatment strategies.

Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases.

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

P304

407-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01303-09

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38027407

http://www.w3.org/2001/XMLSchema#string

P698

19846527

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus

P932

2798422

http://www.w3.org/2001/XMLSchema#string